Northwest Biotherapeutics (NWBO) Preferred Shares (2017)

Northwest Biotherapeutics' Preferred Shares history runs 1 years deep, the most recent figure standing at $12.6 million for Q4 2017.

• In Q4 2017, Preferred Shares changed N/A year-over-year to $12.6 million; the TTM figure through Dec 2017 stood at $12.6 million (changed N/A YoY), while the FY2017 annual figure was $12.6 million, changed N/A from the prior year.
• Preferred Shares for Q4 2017 stood at $12.6 million.
• The five-year high for Preferred Shares was $12.6 million in Q4 2017, with the low at $12.6 million in Q4 2017.